Pulmonary hypertension in COPD: epidemiology, significance, and management: pulmonary vascular disease: the global perspective
- PMID: 20522579
- DOI: 10.1378/chest.10-0087
Pulmonary hypertension in COPD: epidemiology, significance, and management: pulmonary vascular disease: the global perspective
Abstract
Pulmonary hypertension (PH) associated with parenchymal lung diseases is one of the most common forms of PH. Studies in patients with advanced COPD and hypoxemia have shown a very high prevalence of PH; however, prevalence in mild and moderate COPD is not known. Typical hemodynamic abnormalities include mild-to-moderate elevations in pulmonary artery pressure (PAP) and pulmonary vascular resistance with a preserved cardiac output. A small proportion (< 5%) of patients may have significant elevations in PAP (mean PAP > 35-40 mm Hg) in the presence of mild airflow limitation and are believed to have disproportionate PH. COPD-associated PH has significant clinical implications because it can produce functional limitation and has a negative impact on prognosis. Doppler echocardiography is the best noninvasive test, but noninvasive methods used for diagnosis are prone to error and cannot be relied on when making or refuting the diagnosis of PH. All patients require right-sided heart catheterization if treatment with PH-specific medications is contemplated. The most important steps in managing these patients are: (1) confirm the diagnosis; (2) optimize COPD management; (3) rule out comorbidities; (4) assess and treat hypoxemia; and (5) enroll the patient in pulmonary rehabilitation, if indicated. In patients with PH and advanced airflow limitation, lung transplantation offers the best opportunity for long-term benefit. The role of PH-specific medications remains poorly defined and requires further study but may be considered in patients with disproportionate PH.
Similar articles
-
Pulmonary hypertension in chronic lung diseases.J Am Coll Cardiol. 2013 Dec 24;62(25 Suppl):D109-16. doi: 10.1016/j.jacc.2013.10.036. J Am Coll Cardiol. 2013. PMID: 24355635 Review.
-
Pulmonary hypertension in chronic obstructive pulmonary disease.Pneumonol Alergol Pol. 2013;81(4):390-8. Pneumonol Alergol Pol. 2013. PMID: 23744170 Review.
-
Pulmonary hypertension secondary to chronic obstructive pulmonary disease.Rom J Intern Med. 2012 Oct-Dec;50(4):259-68. Rom J Intern Med. 2012. PMID: 23610973 Review.
-
Update on pulmonary hypertension complicating chronic obstructive pulmonary disease.Int J Chron Obstruct Pulmon Dis. 2009;4:351-63. doi: 10.2147/copd.s5102. Epub 2009 Sep 24. Int J Chron Obstruct Pulmon Dis. 2009. PMID: 19802350 Free PMC article. Review.
-
Pulmonary hypertension in chronic obstructive pulmonary disease and interstitial lung diseases.Semin Respir Crit Care Med. 2009 Aug;30(4):458-70. doi: 10.1055/s-0029-1233315. Epub 2009 Jul 24. Semin Respir Crit Care Med. 2009. PMID: 19634085 Review.
Cited by
-
Clinical characteristics and predictors of pulmonary hypertension in chronic obstructive pulmonary disease at different altitudes.BMC Pulm Med. 2023 Apr 18;23(1):127. doi: 10.1186/s12890-023-02405-8. BMC Pulm Med. 2023. PMID: 37072815 Free PMC article.
-
Tensions in Taxonomies: Current Understanding and Future Directions in the Pathobiologic Basis and Treatment of Group 1 and Group 3 Pulmonary Hypertension.Compr Physiol. 2023 Jan 30;13(1):4295-4319. doi: 10.1002/cphy.c220010. Compr Physiol. 2023. PMID: 36715285 Free PMC article. Review.
-
Endotyping COPD: hypoxia-inducible factor-2 as a molecular "switch" between the vascular and airway phenotypes?Eur Respir Rev. 2023 Jan 11;32(167):220173. doi: 10.1183/16000617.0173-2022. Print 2023 Mar 31. Eur Respir Rev. 2023. PMID: 36631133 Free PMC article. Review.
-
Characterization of pulmonary vascular remodeling and MicroRNA-126-targets in COPD-pulmonary hypertension.Respir Res. 2022 Dec 15;23(1):349. doi: 10.1186/s12931-022-02267-4. Respir Res. 2022. PMID: 36522710 Free PMC article.
-
Severe pulmonary hypertension associated with lung disease is characterised by a loss of small pulmonary vessels on quantitative computed tomography.ERJ Open Res. 2022 May 16;8(2):00503-2021. doi: 10.1183/23120541.00503-2021. eCollection 2022 Apr. ERJ Open Res. 2022. PMID: 35586449 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials